ZielBio Competitors and Similar CompaniesClear all

Domain Therapeutics's competitors and similar companies include AEON Biopharma and Cage Bio.
Domain Therapeutics
Domain Therapeutics
Domain Therapeutics is a biopharmaceutical company.
AEON Biopharma
AEON Biopharma
AEON Biopharma (formerly Alphaeon and Priveterra Acquisition) is a clinical-stage biopharmaceutical company developing a botulinum toxin complex for debilitating medical conditions, with an initial focus on neurology and gastroenterology.
Cage Bio
Cage Bio
Cage Bio is a biotechnology company developing an ionic liquid platform.
Founding Date
Founding Date
2001
Founding Date
2012
Founding Date
2017
Type
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Illkirch-Graffenstaden, FR HQ
Montréal, CA
Locations
Irvine, US HQ
Newport Beach, US
Locations
San Carlos, US HQ
Employees
Employees
811% decrease
Employees
6
Employees
13

Funding

Latest funding round
Latest funding round
$ 3.9m (about 7 years ago)
Latest funding round
N/A
Latest funding round
$ 7.2m (over 5 years ago)
Total funding raised
Total funding raised
$ 41.5m
Total funding raised
$ 112.6m
Total funding raised
$ 12.7m
For sources of this data, please see the company profile

View Company Profiles

AEON Biopharma
HQ
Irvine, US
Employees
6

AEON Biopharma (formerly Alphaeon and Priveterra Acquisition) is a clinical-stage biopharmaceutical company developing a botulinum toxin complex for debilitating medical conditions, with an initial focus on neurology and gastroenterology.

View company
Cage Bio
HQ
San Carlos, US
Employees
13

Cage Bio is a biotechnology company developing an ionic liquid platform.

View company